Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
about
Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.
P2860
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@ast
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@en
type
label
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@ast
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@en
prefLabel
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@ast
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@en
P2093
P2860
P1433
P1476
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
@en
P2093
Ching-Ying Chen
Shih-Han Wang
Shin-Cheh Chen
Tsun-Mei Lin
P2860
P2888
P356
10.1186/S12865-016-0183-7
P577
2016-11-25T00:00:00Z
P6179
1005100818